WaferGen Bio Buy or Sell Recommendation

Macroaxis provides WaferGen Bio systems Inc buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding WaferGen Bio positions. The advice algorithm takes into account all of WaferGen Bio systems Inc available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from WaferGen Bio buy-and-hold prospective. See also Your Current Watchlist.

Investment Horizon

  

Risk Tolerance

  
Symbol
Execute Advice
WaferGen Bio systems Inc -- USA Stock  

USD 6.9  0.00  0.00%

Given the investment horizon of 30 days, and your above average risk tolerance our recommendation regarding WaferGen Bio systems Inc is 'Not Rated'.
For the selected time horizon WaferGen Bio systems Inc has a risk adjusted performance of 0.0935, jensen alpha of 1.28, total risk alpha of (1.18), sortino ratio of 1.19 and treynor ratio of (0.63)
We provide recommendation to complement the prevalent expert consensus on WaferGen Bio systems. Our dynamic recommendation engine utilizes multi - dimensional algorithm to analyze the firm potential to grow using all technical and fundamental data available at the time. To make sure WaferGen Bio systems Inc is not overpriced, please check out all WaferGen Bio systems fundamentals including its Price to Book, Cash Flow from Operations, Z Score, as well as the relationship between Cash and Equivalents and Total Asset . Given that WaferGen Bio systems has Number of Shares Shorted of 240.41 K, we strongly advise you confirm WaferGen Bio systems market performance and probability of bankruptcy to make sure the company can sustain itself in the current economic cycle given your prevalent risk tolerance and investing horizon.

Returns Distribution Density

Mean Return1.0Value At Risk-0.7018
Potential Upside2.0833Standard Deviation3.2093
 Return Density 
      Distribution 

Institutional Investors

Security TypeSharesValue
Sabby Management Llc 0Common Shares358.5 K1.8 M
Opaleye Management IncCommon Shares320 K1.6 M
Vanguard Group IncCommon Shares21.1 K104 K
Creative PlanningCommon Shares20.9 K103 K
Ubs Group AgCommon Shares6.3 K31 K
Blackrock Fund AdvisorsCommon Shares1.4 K7 K
Deutsche Bank AgCommon Shares1.00.0
SellBuy
Not Rated
   Acquisition by Hautamaki R Dean of 1250 shares of WaferGen Bio subject to Rule 16b-3 [view details]
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Find Alpha
Equity Screener
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals, sectors and families
Research Equities
Insiders Screener
Find insiders across different sectors to evaluate their impact on performance and growth of their entities
Research Insiders

Current Valuation

WaferGen Bio Current Valuation Analysis
WaferGen Bio systems Inc is rated first in current valuation category among related companies. After adjusting for long-term liabilities, total market size of Measuring and Control Equipment industry is at this time estimated at about 46.68 Billion. WaferGen Bio adds roughly 16.04 Million in current valuation claiming only tiny portion of all equities under Measuring and Control Equipment industry.